Exponent (EXPO) Lifted to “Buy” at BidaskClub
BidaskClub upgraded shares of Exponent (NASDAQ:EXPO) from a hold rating to a buy rating in a report issued on Saturday.
EXPO has been the subject of a number of other reports. Zacks Investment Research raised Exponent from a hold rating to a buy rating and set a $82.00 price target for the company in a research note on Tuesday, January 23rd. SunTrust Banks raised Exponent from a hold rating to a buy rating and set a $84.00 price target for the company in a research note on Friday, January 26th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of Buy and an average price target of $84.67.
Exponent (EXPO) opened at $78.75 on Friday. Exponent has a one year low of $56.95 and a one year high of $80.95. The company has a market capitalization of $2,050.00, a P/E ratio of 36.63 and a beta of 0.65.
The company also recently declared a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 2nd will be paid a dividend of $0.26 per share. The ex-dividend date is Thursday, March 1st. This is a positive change from Exponent’s previous quarterly dividend of $0.21. This represents a $1.04 dividend on an annualized basis and a yield of 1.32%. Exponent’s dividend payout ratio is presently 48.37%.
Institutional investors have recently made changes to their positions in the stock. Trexquant Investment LP bought a new stake in shares of Exponent in the 3rd quarter valued at approximately $224,000. Cubist Systematic Strategies LLC bought a new stake in shares of Exponent in the 3rd quarter valued at approximately $242,000. Stifel Financial Corp bought a new stake in shares of Exponent in the 3rd quarter valued at approximately $249,000. Capital Fund Management S.A. bought a new stake in shares of Exponent in the 4th quarter valued at approximately $277,000. Finally, OppenheimerFunds Inc. lifted its stake in shares of Exponent by 22.5% in the 4th quarter. OppenheimerFunds Inc. now owns 4,428 shares of the business services provider’s stock valued at $315,000 after purchasing an additional 813 shares during the last quarter. 88.91% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Exponent (EXPO) Lifted to “Buy” at BidaskClub” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.thecerbatgem.com/2018/03/14/exponent-expo-lifted-to-buy-at-bidaskclub.html.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.